• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Cancer innovation needs better data—not just better drugs

Cancer innovation needs better data—not just better drugs

by Truveta staff | May 15, 2025 | Data

Cancer is one of the most heavily funded areas of medical research. And yet, with thousands of therapies in development and billions of dollars spent each year, many foundational questions persist: Why do patients stop treatment? How do outcomes vary across...

Share this


Recent posts

  • Truveta Experts: Real-world trends in Rituxan biosimilar adoption
  • Shifting trends in initiation of disease-modifying therapies for multiple sclerosis
  • New AAP guidelines are changing pediatric obesity treatment—but there’s still work to do

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.